Suppression of the immune system as a critical step for bone formation from allogeneic osteoprogenitors implanted in rats

Anindita Ganguly, Vanessa LaPointe, Jacqueline Alblas, Supriyo Chatterjea, Clemens van Blitterswijk, Jan de Boer

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)

Abstract

The surface marker profile of mesenchymal stromal cells (MSCs) suggests that they can escape detection by the immune system of an allogeneic host. This could be an optimal strategy for bone regeneration applications, where off-the-shelf cells could be implanted to heal bone defects. However, it is unknown how pre-differentiation of MSCs to an osteogenic lineage, a means of improving bone formation, affects their immunogenicity. Using immunohistological techniques in a rat ectopic implantation model, we demonstrate that allogeneic osteoprogenitors mount a T cell- and B cell-mediated immune response resulting in an absence of in vivo bone formation. Suppression of the host immune response with daily administration of an immunosuppressant, FK506, is effective in preventing the immune attack on the allogeneic osteoprogenitors. In the immunosuppressed environment, the allogeneic osteoprogenitors are capable of generating bone in amounts similar to those of syngeneic cells. However, using osteoprogenitors from one of the allogeneic donors led to newly deposited bone that was attacked by the host immune system, despite the continued administration of the immunosuppressant. This suggests that, although using an immunosuppressant can potentially suppress the immune attack on the allogeneic cells, optimizing the dose of the immunosuppressant may be crucial to ensure bone formation within the allogeneic environment. Overall, allografts comprising osteoprogenitors derived from allogeneic MSCs have the potential to be used in bone regeneration applications.
Original languageEnglish
Pages (from-to)134-142
JournalJournal of cellular and molecular medicine
Volume18
Issue number1
DOIs
Publication statusPublished - 17 Nov 2014

Fingerprint

Immunosuppressive Agents
Osteogenesis
Immune System
Mesenchymal Stromal Cells
Bone Regeneration
Bone and Bones
Tacrolimus
Allografts
B-Lymphocytes
T-Lymphocytes

Keywords

  • METIS-298725
  • IR-87767

Cite this

Ganguly, Anindita ; LaPointe, Vanessa ; Alblas, Jacqueline ; Chatterjea, Supriyo ; van Blitterswijk, Clemens ; de Boer, Jan. / Suppression of the immune system as a critical step for bone formation from allogeneic osteoprogenitors implanted in rats. In: Journal of cellular and molecular medicine. 2014 ; Vol. 18, No. 1. pp. 134-142.
@article{1cc44b6b13454dc7816113a902e4b64d,
title = "Suppression of the immune system as a critical step for bone formation from allogeneic osteoprogenitors implanted in rats",
abstract = "The surface marker profile of mesenchymal stromal cells (MSCs) suggests that they can escape detection by the immune system of an allogeneic host. This could be an optimal strategy for bone regeneration applications, where off-the-shelf cells could be implanted to heal bone defects. However, it is unknown how pre-differentiation of MSCs to an osteogenic lineage, a means of improving bone formation, affects their immunogenicity. Using immunohistological techniques in a rat ectopic implantation model, we demonstrate that allogeneic osteoprogenitors mount a T cell- and B cell-mediated immune response resulting in an absence of in vivo bone formation. Suppression of the host immune response with daily administration of an immunosuppressant, FK506, is effective in preventing the immune attack on the allogeneic osteoprogenitors. In the immunosuppressed environment, the allogeneic osteoprogenitors are capable of generating bone in amounts similar to those of syngeneic cells. However, using osteoprogenitors from one of the allogeneic donors led to newly deposited bone that was attacked by the host immune system, despite the continued administration of the immunosuppressant. This suggests that, although using an immunosuppressant can potentially suppress the immune attack on the allogeneic cells, optimizing the dose of the immunosuppressant may be crucial to ensure bone formation within the allogeneic environment. Overall, allografts comprising osteoprogenitors derived from allogeneic MSCs have the potential to be used in bone regeneration applications.",
keywords = "METIS-298725, IR-87767",
author = "Anindita Ganguly and Vanessa LaPointe and Jacqueline Alblas and Supriyo Chatterjea and {van Blitterswijk}, Clemens and {de Boer}, Jan",
note = "Early View (Online Version of Record published before inclusion in an issue)",
year = "2014",
month = "11",
day = "17",
doi = "10.1111/jcmm.12172",
language = "English",
volume = "18",
pages = "134--142",
journal = "Journal of cellular and molecular medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "1",

}

Suppression of the immune system as a critical step for bone formation from allogeneic osteoprogenitors implanted in rats. / Ganguly, Anindita; LaPointe, Vanessa; Alblas, Jacqueline; Chatterjea, Supriyo; van Blitterswijk, Clemens; de Boer, Jan.

In: Journal of cellular and molecular medicine, Vol. 18, No. 1, 17.11.2014, p. 134-142.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Suppression of the immune system as a critical step for bone formation from allogeneic osteoprogenitors implanted in rats

AU - Ganguly, Anindita

AU - LaPointe, Vanessa

AU - Alblas, Jacqueline

AU - Chatterjea, Supriyo

AU - van Blitterswijk, Clemens

AU - de Boer, Jan

N1 - Early View (Online Version of Record published before inclusion in an issue)

PY - 2014/11/17

Y1 - 2014/11/17

N2 - The surface marker profile of mesenchymal stromal cells (MSCs) suggests that they can escape detection by the immune system of an allogeneic host. This could be an optimal strategy for bone regeneration applications, where off-the-shelf cells could be implanted to heal bone defects. However, it is unknown how pre-differentiation of MSCs to an osteogenic lineage, a means of improving bone formation, affects their immunogenicity. Using immunohistological techniques in a rat ectopic implantation model, we demonstrate that allogeneic osteoprogenitors mount a T cell- and B cell-mediated immune response resulting in an absence of in vivo bone formation. Suppression of the host immune response with daily administration of an immunosuppressant, FK506, is effective in preventing the immune attack on the allogeneic osteoprogenitors. In the immunosuppressed environment, the allogeneic osteoprogenitors are capable of generating bone in amounts similar to those of syngeneic cells. However, using osteoprogenitors from one of the allogeneic donors led to newly deposited bone that was attacked by the host immune system, despite the continued administration of the immunosuppressant. This suggests that, although using an immunosuppressant can potentially suppress the immune attack on the allogeneic cells, optimizing the dose of the immunosuppressant may be crucial to ensure bone formation within the allogeneic environment. Overall, allografts comprising osteoprogenitors derived from allogeneic MSCs have the potential to be used in bone regeneration applications.

AB - The surface marker profile of mesenchymal stromal cells (MSCs) suggests that they can escape detection by the immune system of an allogeneic host. This could be an optimal strategy for bone regeneration applications, where off-the-shelf cells could be implanted to heal bone defects. However, it is unknown how pre-differentiation of MSCs to an osteogenic lineage, a means of improving bone formation, affects their immunogenicity. Using immunohistological techniques in a rat ectopic implantation model, we demonstrate that allogeneic osteoprogenitors mount a T cell- and B cell-mediated immune response resulting in an absence of in vivo bone formation. Suppression of the host immune response with daily administration of an immunosuppressant, FK506, is effective in preventing the immune attack on the allogeneic osteoprogenitors. In the immunosuppressed environment, the allogeneic osteoprogenitors are capable of generating bone in amounts similar to those of syngeneic cells. However, using osteoprogenitors from one of the allogeneic donors led to newly deposited bone that was attacked by the host immune system, despite the continued administration of the immunosuppressant. This suggests that, although using an immunosuppressant can potentially suppress the immune attack on the allogeneic cells, optimizing the dose of the immunosuppressant may be crucial to ensure bone formation within the allogeneic environment. Overall, allografts comprising osteoprogenitors derived from allogeneic MSCs have the potential to be used in bone regeneration applications.

KW - METIS-298725

KW - IR-87767

U2 - 10.1111/jcmm.12172

DO - 10.1111/jcmm.12172

M3 - Article

VL - 18

SP - 134

EP - 142

JO - Journal of cellular and molecular medicine

JF - Journal of cellular and molecular medicine

SN - 1582-1838

IS - 1

ER -